Actuate Therapeutics, Inc. Common stock
ACTU
$0.48-7.94%
End of day · as of Oct 24, 2026, 8:00 AM ET
Mkt cap
$49.05M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.44
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Use this ACTU research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ACTU income, balance, and cash tables.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company in the Healthcare sector.
Latest cached Actuate Therapeutics, Inc. Common stock (ACTU) net income for FY2025 was -$22.2M. Statements: https://lician.com/financials/actu
Actuate Therapeutics, Inc. Common stock (ACTU) market capitalization is $49.0M on the latest cached snapshot.
Actuate Therapeutics, Inc. Common stock (ACTU) cached previous close $0.52; day range $0.45 – $0.56; volume 253,869. Session quote: https://lician.com/quote/actu
Actuate Therapeutics, Inc. Common stock (ACTU) latest cached earnings event is "ACTU earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ACTU filing is 8-K · Jul 17, 2026. Filings: https://lician.com/sec/actu